choriogonadotropin alfa (Ovidrel)
choriogonadotropin alfa is an FDA-licensed reference biologic from EMD Serono, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2000
Reference approved
Reference product
Ovidrel choriogonadotropin alfa
EMD Serono, Inc.
- Approved
- Sep 20, 2000
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for choriogonadotropin alfa, in chronological order.
Reference approval
Approval date of the reference choriogonadotropin alfa product.
26 yr 1 mo ago
Frequently asked questions
Are there biosimilars approved for choriogonadotropin alfa (Ovidrel)?
No 351(k) biosimilars or interchangeable biosimilars referencing choriogonadotropin alfa are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.